PV Bulletin

ANSM (France) - Safety information feed: Ventilateur d'anesthésie – Systèmes d’anesthésie Aisys et AisysCS2 – GE Healthcare / Datex-Ohmeda sur le site de l'Agence nationale de sécurité du médicamentet des produits de santé Information de sé

Urgent safety notification regarding anesthesia ventilators Aisys and AisysCS2 from GE Healthcare due to potential automatic switching to emergency O2 mode, requiring clinician intervention.

Primary source: Téléchargez le courrier de la société GE Healthcare (31/08/2026)

Translated From French

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

Urgency: HighConfidence: high

What changed

Healthcare facilities are required to perform preoperative checks and adjust emergency O2 flow based on patient needs when this mode is activated. GE Healthcare is to inspect and correct affected products at no charge, with healthcare facilities required to respond to the notification within 30 days.

Why it matters

This safety issue poses a risk to patient safety by potentially reducing the anesthetic effect during surgeries. It is crucial for healthcare facilities to follow the recommended actions to ensure patient safety and regulatory compliance.

Action needed

Healthcare facilities must complete preoperative checks, manage emergency O2 flow during usage, and return the response form to GE Healthcare within a maximum of 30 days.

Relevant for
Regulatory Intelligence LeadMedical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Aug 31, 2026

Full briefing

Practical implication

Healthcare facilities must complete preoperative checks, manage emergency O2 flow during usage, and return the response form to GE Healthcare within a maximum of 30 days.

The ANSM (France) issued a safety notice concerning GE Healthcare anesthesia ventilators Aisys CS2, Aisys CS2 with FetCible, and S/5 Aisys due to an issue that may cause the systems to automatically switch to an emergency O2 mode, which interrupts halogen agent delivery and could affect patient safety. Although no injuries have been reported, this requires immediate attention and corrective actions by healthcare facilities.

What changed: Healthcare facilities are required to perform preoperative checks and adjust emergency O2 flow based on patient needs when this mode is activated. GE Healthcare is to inspect and correct affected products at no charge, with healthcare facilities required to respond to the notification within 30 days.

Why it matters: This safety issue poses a risk to patient safety by potentially reducing the anesthetic effect during surgeries. It is crucial for healthcare facilities to follow the recommended actions to ensure patient safety and regulatory compliance.

Practical implication: Healthcare facilities must complete preoperative checks, manage emergency O2 flow during usage, and return the response form to GE Healthcare within a maximum of 30 days.

View original source

  • Source: ANSM (France) - Safety information feed
  • Published at source: 2026-08-31T00:00:00.000Z
  • Discovered by monitor: 2026-08-31T21:32:57.875Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Aug 31, 2026

International Collaboration to Advance New Testing Methods That Reduce Reliance on Horseshoe Crab Blood

Urgency: High

Regulatory compliance processes may need updates to incorporate the new recombinant endotoxins testing method and guidelines established under the ICMRA framework.

Inspection ReadinessCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, PV Quality Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Aug 31, 2026Translated From French

Withdrawal of FastPen 40mg Product by AZRL LTD

Urgency: High

AZRL LTD must proceed with the recall of FastPen 40mg from all locations and suspend marketing activities until compliance is verified.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Aug 31, 2026Translated From French

Beckman Coulter Iris iQ200 and DxU 840m/850m Analyzers Safety Notification

Urgency: High

All users of the affected analyzers are required to reply to the notification letter within 10 days and implement increased monitoring of device performance to prevent liquid leaks.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Aug 31, 2026Translated From French

ANSM (France) - Safety information feed: Mycologie – Réactif Yeastone Broth, 11ML – Thermo Fisher Scientific sur le site de l'Agence nationale de sécurité du médicamentet des produits de santé Information de sécurité - Mycologie – Réactif Yeasto

Urgency: High

Laboratories must immediately quarantine and return the affected product, and communicate with patients to manage their follow-up testing appropriately.

Signal ManagementCountry ComplianceRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward